Literature DB >> 4648543

The in-vitro activity of tobramycin compared with that of other aminoglycosides.

P M Waterworth.   

Abstract

The influence of medium composition, pH, serum, and magnesium on the action of tobramycin is compared to that on the action of gentamicin. The minimum inhibitory concentration of tobramycin, gentamicin, kanamycin, and streptomycin was determined for 472 strains including 19 species: tobramycin was found to be the most active against Ps. aeruginosa and kanamycin against Providence, but gentamicin was usually the most active against all other species. Ps. aeruginosa passaged on medium containing either gentamicin or tobramycin showed increased resistance to both. Sensitive strains of this species were shown to contain a small minority of cells resistant to these antibiotics, the presence of which is believed to account for the marked bactericidal synergy which was demonstrated between tobramycin and carbenicillin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4648543      PMCID: PMC477579          DOI: 10.1136/jcp.25.11.979

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Preclinical assessment of the antibacterial activity of nebramycin factor 6.

Authors:  D A Preston; W E Wick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

2.  Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro.

Authors:  M Sonne; E Jawetz
Journal:  Appl Microbiol       Date:  1969-06

3.  Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

Authors:  W E Wick; J S Welles
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

4.  Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis.

Authors:  W M Stark; M M Hoehn; N G Knox
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

5.  Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius.

Authors:  C E Higgins; R E Kastner
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

6.  Nebramycin, a new broad-spectrum antibiotic complex. 3. Isolation and chemical-physical properties.

Authors:  R Q Thompson; E A Presti
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

7.  Dosage of gentamicin for pseudomonas infections.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1967-05-27

8.  Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Authors:  R D Meyer; L S Young; D Armstrong
Journal:  Appl Microbiol       Date:  1971-12

9.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01

10.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

  10 in total
  12 in total

Review 1.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Specific and non-specific resistance to aminoglycosides in Escherichia coli.

Authors:  S L Mawer; D Greenwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

3.  A critical investigation into the antibiotic sterilization of heart valve homografts.

Authors:  P M Waterworth; E Lockey; E M Berry; H M Pearce
Journal:  Thorax       Date:  1974-07       Impact factor: 9.139

4.  Use of tobramycin in eradicating experimental bacterial endophthalmitis.

Authors:  T O Bennett; G A Peyman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

5.  Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.

Authors:  F A Drasar; W Farrell; J Maskell; J D Williams
Journal:  Br Med J       Date:  1976-11-27

6.  Pneumonia caused by coliforms and Pseudomonas aeruginosa.

Authors:  P Noone; B T Rogers
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

7.  [Antibacterial activity of antibiotics in human bile (author's transl)].

Authors:  E B Helm; I Paulus; P M Shah; W Stille
Journal:  Infection       Date:  1976       Impact factor: 3.553

Review 8.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.

Authors:  J H Jorgensen; J C Lee; P M Jones
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

10.  Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.

Authors:  E T Houang; D Greenwood
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.